References
- World Health Organisation. Tobacco Geneva, Switzerland: World Health Organisation. 2025. At: www.who.int/news-room/fact-sheets/detail/tobacco
- Addiction Expert Group. Overview of tobacco smoking and nicotine dependence. 2023. Melbourne (AU): Therapeutic Guidelines Ltd. At: www.tg.org.au
- US Centers for Disease Control and Prevention. Smoking Cessation: Fast Facts US: US Centers for Disease Control and Prevention. 2024 At: www.cdc.gov/tobacco/php/data-statistics/smoking-cessation/index.html#:~:text=the%20past%20year.-,Less%20than%201%20in%2010%20adults%20who%20smoke%20cigarettes%20succeed,smoking%20in%20the%20past%20year
- Conley M. Five things to know about GLP-1s and addiction US: Standford Medicine. 2023. At: https://med.stanford.edu/news/insights/2025/04/ozempic-addiction-glp-1s-mounjaro-lembke.html
- Wang W, Volkow N, Berger N, et al. Association of semaglutide with tobacco use disorder in patients with type 2 diabetes: target trial emulation using real-world data. Ann Intern Med 2024;177(8):1016–27.
- Popovic D, Patoulias D, Koufakis T, et al. Semaglutide and smoking cessation in individuals with type 2 diabetes mellitus: there is no smoke without fire! Expert Rev Clin Pharmacol. 2024;17(11):1009–12.
- Australian Medicines Handbook online [Internet]. Doxycycline. 2025. Adelaide (AU): Australian Medicines Handbook Pty Ltd. At: https://amhonline.amh.net.au/auth
